Rhei Life is a Serbia-based startup focused on delivering success to its partners in the global healthcare industry through unique, cutting-edge, and innovative solutions. Since its establishment in 2015, the company has positioned itself as a collaboration partner and solution provider for various healthcare companies worldwide. Rhei Life operates across three divisions: Consumer Healthcare (CHC), Hospital Medicines, and Unregistered Medicines.
The company's portfolio spans across a diverse range of therapeutical areas, covering almost all ATC codes and product classifications, including Rx, Hx, OTC, Food Supplement, and Medical Devices. Rhei Life's business model hinges on developing, delivering, promoting, and securing medicines and other products globally, aiming to reach millions of patients through either conservative or innovative therapy.
Although specific details about the last investment and investors are not available, the company's commitment to innovative cooperation models and a robust product pipeline reflects a strong focus on shaping its future in the Manufacturing and Pharmaceutical industries. Rhei Life's dedication to bringing unique and high-quality products to the global market underlines its potential for further growth and impact in the healthcare sector.